{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:23:17Z","timestamp":1791235397229,"version":"4.1.0"},"reference-count":136,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Otolaryngologic Clinics of North America"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.otc.2021.05.019","type":"journal-article","created":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T00:48:28Z","timestamp":1631839708000},"page":"1037-1056","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Current and Emerging Medical Therapies for Dizziness"],"prefix":"10.1016","volume":"54","author":[{"given":"Mallory J.","family":"Raymond","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther X.","family":"Vivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.otc.2021.05.019_bib1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2174\/157015910790909511","article-title":"Neuropharmacology of vestibular system disorders","volume":"8","author":"Soto","year":"2010","journal-title":"Curr Neuropharmacol"},{"issue":"1\u20132","key":"10.1016\/j.otc.2021.05.019_bib2","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0006-8993(94)91551-2","article-title":"Evidence for NMDA receptor in the afferent synaptic transmission of the vestibular system","volume":"633","author":"Soto","year":"1994","journal-title":"Brain Res"},{"key":"10.1016\/j.otc.2021.05.019_bib3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0006-8993(98)00997-4","article-title":"Nitric oxide synthase in the vestibulocochlear system of mice","volume":"813","author":"Hess","year":"1998","journal-title":"Brain Res"},{"key":"10.1016\/j.otc.2021.05.019_bib4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0304-3940(99)00195-0","article-title":"Expression of inducible nitric oxide synthase in the vestibular system of hydropic guinea pigs","volume":"264","author":"Hess","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.otc.2021.05.019_bib5","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0306-4522(99)00159-1","article-title":"Opioid peptides as possible neuromodulators of the afferent synaptic transmission in the frog semicircular canal","volume":"93","author":"Andrianov","year":"1999","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.otc.2021.05.019_bib6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3233\/VES-130494","article-title":"Neuropharmacological basis of vestibular system disorder treatment","volume":"23","author":"Soto","year":"2013","journal-title":"J\u00a0Vestib Res"},{"issue":"4","key":"10.1016\/j.otc.2021.05.019_bib7","first-page":"293","article-title":"Central histaminergic modulation of vestibular function - a review","volume":"58","author":"Bergquist","year":"2006","journal-title":"Sheng Li Xue Bao"},{"issue":"1","key":"10.1016\/j.otc.2021.05.019_bib8","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neuroscience.2007.03.049","article-title":"Selective anterograde tracing of the individual serotonergic and nonserotonergic components of the dorsal raphe nucleus projection to the vestibular nuclei","volume":"147","author":"Halberstadt","year":"2007","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.otc.2021.05.019_bib9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0028-3908(75)90006-4","article-title":"Cholinergic mechanisms in the cat vestibular system","volume":"14","author":"Matsuoka","year":"1975","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.otc.2021.05.019_bib10","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s002210050507","article-title":"Opioid inhibition of rat medial vestibular nucleus neurones in\u00a0vitro and its dependence on age","volume":"122","author":"Sulaiman","year":"1998","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.otc.2021.05.019_bib11","series-title":"Vertigo and disequilibrium a practical guide to diagnosis and management","article-title":"Medications used in treating acute and chronic vertigo and various vestibular disorders","author":"Colby","year":"2017"},{"issue":"5","key":"10.1016\/j.otc.2021.05.019_bib12","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2165\/00003495-199550050-00002","article-title":"Antivertigo medications and drug-induced vertigo. A pharmacological review","volume":"50","author":"Rascol","year":"1995","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.otc.2021.05.019_bib13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00019052-200002000-00007","article-title":"Pharmacology of the vestibular system","volume":"13","author":"Smith","year":"2000","journal-title":"Curr Opin Neurol"},{"issue":"2_suppl","key":"10.1016\/j.otc.2021.05.019_bib14","first-page":"S1","article-title":"Clinical practice guideline: M\u00e9ni\u00e8re's disease","volume":"162","author":"Basura","year":"2020","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.otc.2021.05.019_bib15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0014-2999(85)90115-3","article-title":"Actions of betahistine at histamine receptors in the brain","volume":"111","author":"Arrang","year":"1985","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.otc.2021.05.019_bib16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/BF00242178","article-title":"Effects of histamine and betahistine on rat medial vestibular nucleus neurones: possible mechanism of action of anti-histaminergic drugs in vertigo and motion sickness","volume":"105","author":"Wang","year":"1995","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.otc.2021.05.019_bib17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/00016487209122697","article-title":"The effect of Serc (betahistine hydrochloride) on the circulation of the inner ear in experimental animals","volume":"305","author":"Mart\u00ednez","year":"1972","journal-title":"Acta Otolaryngol"},{"issue":"6","key":"10.1016\/j.otc.2021.05.019_bib18","article-title":"Betahistine for symptoms of vertigo","author":"Murdin","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.otc.2021.05.019_bib19","doi-asserted-by":"crossref","first-page":"h6816","DOI":"10.1136\/bmj.h6816","article-title":"Efficacy and safety of betahistine treatment in patients with Meniere's disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial)","volume":"352","author":"Adrion","year":"2016","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.otc.2021.05.019_bib20","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1111\/head.13414","article-title":"Recommendations on the use of Anti-CGRP monoclonal antibodies in children and adolescents","volume":"58","author":"Szperka","year":"2018","journal-title":"Headache"},{"issue":"10","key":"10.1016\/j.otc.2021.05.019_bib21","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1517\/14656560902976879","article-title":"Medical treatment of vestibular disorders","volume":"10","author":"Brandt","year":"2009","journal-title":"Expert Opin Pharmacother"},{"issue":"3","key":"10.1016\/j.otc.2021.05.019_bib22","first-page":"529","article-title":"Pharmacology of balance and dizziness","volume":"32","author":"Lin","year":"2013","journal-title":"NeuroRehabilitation"},{"key":"10.1016\/j.otc.2021.05.019_bib23","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.brainres.2010.05.057","article-title":"Distribution of 5-HT1B and 5- HT1D receptors in the inner ear","volume":"1346","author":"Ahn","year":"2010","journal-title":"Brain Res"},{"issue":"4\u20135","key":"10.1016\/j.otc.2021.05.019_bib24","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0031-9384(02)00935-6","article-title":"Neural substrates linking balance control and anxiety","volume":"77","author":"Balaban","year":"2002","journal-title":"Physiol Behav"},{"issue":"1","key":"10.1016\/j.otc.2021.05.019_bib25","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/lary.28546","article-title":"Treatment of vestibular migraine: a systematic review and meta-analysis","volume":"131","author":"Byun","year":"2021","journal-title":"Laryngoscope"},{"issue":"10","key":"10.1016\/j.otc.2021.05.019_bib26","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1080\/14656566.2019.1610386","article-title":"Advances in pharmacotherapy of vestibular and ocular motor disorders","volume":"20","author":"Zwergal","year":"2019","journal-title":"Expert Opin Pharmacother"},{"issue":"4","key":"10.1016\/j.otc.2021.05.019_bib27","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2147\/nedt.2006.2.4.475","article-title":"Psychopharmacology of topiramate: from epilepsy to bipolar disorder","volume":"2","author":"Mula","year":"2006","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"1","key":"10.1016\/j.otc.2021.05.019_bib28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1526-4610.2009.01496.x","article-title":"Clinical assessment of topiramate therapy in patients with migrainous vertigo","volume":"50","author":"Gode","year":"2010","journal-title":"Headache"},{"key":"10.1016\/j.otc.2021.05.019_bib29","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.phrs.2017.07.026","article-title":"Antihypertensive drugs","volume":"124","author":"Laurent","year":"2017","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.otc.2021.05.019_bib30","first-page":"S1","article-title":"Clinical practice guideline: benign paroxysmal positional vertigo (update)","volume":"156","author":"Bhattacharyya","year":"2017","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.otc.2021.05.019_bib31","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1017\/S0022215110002781","article-title":"Epley\u2019s manoeuvre versus Epley\u2019s manoeuvre plus labyrinthine sedative as management of benign paroxysmal positional vertigo: prospective, randomised study","volume":"125","author":"Sundararajan","year":"2011","journal-title":"J\u00a0Laryngol Otol"},{"issue":"3","key":"10.1016\/j.otc.2021.05.019_bib32","first-page":"832","article-title":"Decreased serum vitamin D in idiopathic benign paroxysmal positional vertigo","volume":"260","author":"Jeong","year":"2013","journal-title":"J\u00a0Neurol"},{"issue":"2","key":"10.1016\/j.otc.2021.05.019_bib33","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.mehy.2012.11.029","article-title":"Vitamin D deficiency and benign paroxysmal positioning vertigo","volume":"80","author":"Buki","year":"2013","journal-title":"Med Hypotheses"},{"issue":"9","key":"10.1016\/j.otc.2021.05.019_bib34","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1007\/s00405-014-3175-3","article-title":"Low bone mineral density and vitamin D deficiency in patients with benign positional paroxysmal vertigo","volume":"272","author":"Talaat","year":"2015","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"6","key":"10.1016\/j.otc.2021.05.019_bib35","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/lio2.35","article-title":"Serum vitamin D and recurrent benign paroxysmal positional vertigo","volume":"1","author":"Rhim","year":"2016","journal-title":"Laryngoscope Investig Otolaryngol"},{"key":"10.1016\/j.otc.2021.05.019_bib36","doi-asserted-by":"crossref","first-page":"742","DOI":"10.3389\/fneur.2018.00742","article-title":"Assessment of bone metabolism in male patients with benign paroxysmal positional vertigo","volume":"9","author":"Wu","year":"2018","journal-title":"Front Neurol"},{"issue":"5\u20136","key":"10.1016\/j.otc.2021.05.019_bib37","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3233\/VES-170625","article-title":"Bone mineral density and serum 25-hydroxyvitamin D in patients with idiopathic benign paroxysmal positional vertigo","volume":"27","author":"Yang","year":"2018","journal-title":"J\u00a0Vestib Res"},{"issue":"5","key":"10.1016\/j.otc.2021.05.019_bib38","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/00016489.2017.1416168","article-title":"Low 25-hydroxyvitamin D levels in postmenopausal female patients with benign paroxysmal positional vertigo","volume":"138","author":"Han","year":"2018","journal-title":"Acta Otolaryngol"},{"issue":"1","key":"10.1016\/j.otc.2021.05.019_bib39","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.brainres.2006.02.083","article-title":"Assembly of the otoconia complex to the macular sensory epithelium of the vestibule","volume":"1091","author":"Lundberg","year":"2006","journal-title":"Brain Res"},{"key":"10.1016\/j.otc.2021.05.019_bib40","article-title":"Prevention of recurrent benign paroxysmal positional vertigo with vitamin D supplementation: a meta-analysis [published online ahead of print, 2020 Aug 7]","author":"Jeong","year":"2020","journal-title":"J\u00a0Neurol"},{"issue":"9","key":"10.1016\/j.otc.2021.05.019_bib41","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1212\/WNL.0000000000010349","article-title":"Randomized controlled trial in support of vitamin D and calcium supplementation for BPPV","volume":"95","author":"Bigelow","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.otc.2021.05.019_bib42","first-page":"150","article-title":"Current views on treatment of vertigo and dizziness","volume":"3","author":"Zatonski","year":"2014","journal-title":"J\u00a0Med Diagn Meth"},{"key":"10.1016\/j.otc.2021.05.019_bib43","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ncl.2015.04.012","article-title":"Acute unilateral vestibulopathy","volume":"33","author":"Strupp","year":"2015","journal-title":"Neurol Clin"},{"key":"10.1016\/j.otc.2021.05.019_bib44","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00405-002-0524-4","article-title":"Betahistine dihydrochloride in the treatment of peripheral vestibular vertigo","volume":"260","author":"Mira","year":"2003","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.otc.2021.05.019_bib45","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1067\/mem.2000.110580","article-title":"Intravenous lorazepam versus dimenhydrinate for treatment of vertigo in the emergency department: a randomized clinical trial","volume":"36","author":"Marill","year":"2000","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.otc.2021.05.019_bib46","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00129492-200205000-00023","article-title":"New approaches to the management of peripheral vertigo: efficacy and safety of two calcium antagonists in a 12-week, multinational, double-blind study","volume":"23","author":"Pianese","year":"2002","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.otc.2021.05.019_bib47","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1197\/aemj.9.6.650","article-title":"Intramuscular droperidol versus intramuscular dimenhydrinate for the treatment of acute peripheral vertigo in the emergency department: a randomized clinical trial","volume":"9","author":"Irving","year":"2002","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.otc.2021.05.019_bib48","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1001\/archotol.1990.01870060058010","article-title":"The beneficial effect of methylprednisolone in acute vestibular vertigo","volume":"116","author":"Ariyasu","year":"1990","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"2","key":"10.1016\/j.otc.2021.05.019_bib49","doi-asserted-by":"crossref","first-page":"138","DOI":"10.5152\/iao.2015.1169","article-title":"Histamine antagonists for treatment of peripheral vertigo: a meta-analysis","volume":"11","author":"Amini","year":"2015","journal-title":"J\u00a0Int Adv Otol"},{"issue":"9","key":"10.1016\/j.otc.2021.05.019_bib50","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/WOX.0b013e318186fb3a","article-title":"H1 antihistamines: current status and future directions","volume":"1","author":"Simons","year":"2008","journal-title":"World Allergy Organ J"},{"issue":"12","key":"10.1016\/j.otc.2021.05.019_bib51","first-page":"994","article-title":"A\u00a0comparison of the effects and side effects of oral betahistine with injectable promethazine in the treatment of acute peripheral vertigo in emergency","volume":"9","author":"Motamed","year":"2017","journal-title":"J\u00a0Clin Med Res"},{"issue":"1","key":"10.1016\/j.otc.2021.05.019_bib52","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.amjoto.2018.09.010","article-title":"Ondansetron or promethazine: which one is better for the treatment of acute peripheral vertigo?","volume":"40","author":"Saberi","year":"2019","journal-title":"Am J Otolaryngol"},{"issue":"1","key":"10.1016\/j.otc.2021.05.019_bib53","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3233\/VES-130506","article-title":"Intravenous promethazine versus lorazepam for the treatment of peripheral vertigo in the emergency department: a double blind, randomized clinical trial of efficacy and safety","volume":"24","author":"Amini","year":"2014","journal-title":"J\u00a0Vestib Res"},{"issue":"149","key":"10.1016\/j.otc.2021.05.019_bib54","first-page":"88","article-title":"Intravenous promethazine versus diazepam for treatment of peripheral vertigo in emergency department","volume":"27","author":"Shafipour","year":"2017","journal-title":"J\u00a0Mazandaran Univ Med Sci"},{"key":"10.1016\/j.otc.2021.05.019_bib55","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2165\/11632410-000000000-00000","article-title":"Comparison of the therapeutic efficacy of a fixed low-dose combination of cinnarizine and dimenhydrinate with betahistine in vestibular neuritis: a randomized, double-blind, non-inferiority study","volume":"32","author":"Scholtz","year":"2012","journal-title":"Clin Drug Invest"},{"issue":"2","key":"10.1016\/j.otc.2021.05.019_bib56","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2165\/00044011-200828020-00003","article-title":"A\u00a0fixed combination of cinnarizine\/dimenhydrinate for the treatment of patients with acute vertigo due to vestibular disorders: a randomized, reference-controlled clinical study","volume":"28","author":"Hahn","year":"2008","journal-title":"Clin Drug Invest"},{"issue":"11","key":"10.1016\/j.otc.2021.05.019_bib57","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s00228-019-02741-x","article-title":"Cinnarizine\/betahistine combination vs. the respective monotherapies in acute peripheral vertigo: a randomized triple-blind placebo-controlled trial","volume":"75","author":"Asadi","year":"2019","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.otc.2021.05.019_bib58","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/WCO.0000000000000649","article-title":"Peripheral vestibular disorders: an update","volume":"32","author":"Strupp","year":"2019","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.otc.2021.05.019_bib59","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJMoa033280","article-title":"Methylprednisolone, valacyclovir, or the combination for vestibular neuritis","volume":"351","author":"Strupp","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.otc.2021.05.019_bib60","first-page":"2578","article-title":"Glucocorticoids improve acute dizziness symptoms following acute unilateral vestibulopathy","volume":"262","author":"Batuecas-Caletrio","year":"2015","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.otc.2021.05.019_bib61","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/MAO.0b013e3182267e24","article-title":"Treatment of acute vestibular neuronitis with glucocorticoids","volume":"32","author":"Karlberg","year":"2011","journal-title":"Otol Neurotol"},{"issue":"2","key":"10.1016\/j.otc.2021.05.019_bib62","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/MAO.0b013e3181ca843d","article-title":"Corticosteroids in the treatment of vestibular neuritis: a systematic review and meta-analysis","volume":"31","author":"Goudakos","year":"2010","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.otc.2021.05.019_bib63","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3233\/VES-180645","article-title":"Corticosteroids versus vestibular rehabilitation in long-term outcomes in vestibular neuritis","volume":"28","author":"Ismail","year":"2019","journal-title":"J\u00a0Vestib Res"},{"issue":"5","key":"10.1016\/j.otc.2021.05.019_bib64","article-title":"Corticosteroids for the treatment of idiopathic acute vestibular dysfunction (vestibular neuritis)","author":"Fishman","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.otc.2021.05.019_bib65","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/MAO.0000000000002106","article-title":"Steroids for acute vestibular neuronitits \u2013 the earlier treatment, the better the outcome?","volume":"40","author":"Sjorgen","year":"2019","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.otc.2021.05.019_bib66","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/B978-0-444-63437-5.00014-5","article-title":"Principles of vestibular pharmacotherapy","volume":"137","author":"Chabbert","year":"2016","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.otc.2021.05.019_bib67","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3389\/fneur.2019.00147","article-title":"Ginkgo biloba extract EGb 761 improves vestibular compensation and modulates cerebral vestibular networks in the rat","volume":"10","author":"Lindner","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.otc.2021.05.019_bib68","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3389\/fneur.2018.00431","article-title":"Betahistine treatment in a cat model of vestibular pathology: pharmacokinetic and pharmacodynamic approaches","volume":"9","author":"Tighilet","year":"2018","journal-title":"Front Neurol"},{"key":"10.1016\/j.otc.2021.05.019_bib69","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s00106-006-1440-5","article-title":"Special ginkgo extract in cases of vertigo: a systematic review of randomised, double- blind, placebo controlled clinical examinations","volume":"55","author":"Hamann","year":"2007","journal-title":"HNO"},{"issue":"5\u20136","key":"10.1016\/j.otc.2021.05.019_bib70","first-page":"409","article-title":"Vestibular paroxysmia: diagnostic criteria","volume":"26","author":"Strupp","year":"2016","journal-title":"J\u00a0Vestib Res"},{"issue":"13","key":"10.1016\/j.otc.2021.05.019_bib71","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1212\/01.wnl.0000326594.91291.f8","article-title":"Vestibular paroxysmia: diagnostic features and medical treatment","volume":"71","author":"Hufner","year":"2008","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.otc.2021.05.019_bib72","first-page":"291","article-title":"A\u00a0randomized double-blind, placebo-controlled, cross-over trial (Vestparoxy) of the treatment of vestibular paroxysmia with oxcarbazepine","volume":"265","author":"Bayer","year":"2018","journal-title":"J\u00a0Neurol"},{"issue":"3","key":"10.1016\/j.otc.2021.05.019_bib73","article-title":"Diuretics for M\u00e9ni\u00e8re's disease or syndrome","author":"Thirlwall","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.otc.2021.05.019_bib74","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1002\/lary.1977.87.11.1870","article-title":"Old and new in M\u00e9ni\u00e8re disease","volume":"87","author":"Torok","year":"1977","journal-title":"Laryngoscope"},{"issue":"5","key":"10.1016\/j.otc.2021.05.019_bib75","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1097\/01.mao.0000185057.81962.51","article-title":"Oral administration of prednisone to control refractory vertigo in M\u00e9ni\u00e8re\u2019s disease: a pilot study","volume":"26","author":"Morales-Luckie","year":"2005","journal-title":"Otol Neurotol"},{"issue":"2","key":"10.1016\/j.otc.2021.05.019_bib76","first-page":"230","article-title":"Effect of transtympanic injection of steroids on cochlear blood flow, auditory sensitivity, and histology in the guinea pig","volume":"19","author":"Shirwany","year":"1998","journal-title":"Am J Otol"},{"issue":"6","key":"10.1016\/j.otc.2021.05.019_bib77","doi-asserted-by":"crossref","first-page":"F1127","DOI":"10.1152\/ajprenal.00387.2003","article-title":"Glucocorticoids stimulate cation absorption by semicircular canal duct epithelium via epithelial sodium channel","volume":"286","author":"Pondugula","year":"2004","journal-title":"Am J Physiol Ren Physiol"},{"issue":"2","key":"10.1016\/j.otc.2021.05.019_bib78","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/00016480802078119","article-title":"Cochlear blood flow during occlusion and reperfusion of the anterior inferior cerebellar artery\u2014effect of topical application of dexamethasone to the round window","volume":"129","author":"Otake","year":"2009","journal-title":"Acta Otolaryngol"},{"issue":"9","key":"10.1016\/j.otc.2021.05.019_bib79","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1007\/s00405-015-3689-3","article-title":"Intratympanic corticosteroids injections: a systematic review of literature","volume":"273","author":"Lavigne","year":"2016","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"3","key":"10.1016\/j.otc.2021.05.019_bib80","first-page":"117","article-title":"Intratympanic corticosteroids in M\u00e9ni\u00e8re\u2019s disease: a mini-review","volume":"12","author":"Patel","year":"2017","journal-title":"J\u00a0Otol"},{"issue":"1","key":"10.1016\/j.otc.2021.05.019_bib81","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF02907620","article-title":"Intratympanic dexamethasone application in M\u00e9ni\u00e8re\u2019s disease\u2014is it superior to conventional therapy?","volume":"57","author":"Paragache","year":"2005","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"issue":"7","key":"10.1016\/j.otc.2021.05.019_bib82","article-title":"Intratympanic steroids for M\u00e9ni\u00e8re\u2019s disease or syndrome","author":"Phillips","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.otc.2021.05.019_bib83","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1097\/MAO.0000000000001227","article-title":"Intratympanic sustained-exposure dexamethasone thermosensitive gel for symptoms of M\u00e9ni\u00e8re\u2019s disease: randomized phase 2b safety and efficacy trial","volume":"37","author":"Lambert","year":"2016","journal-title":"Otol Neurotol"},{"issue":"3","key":"10.1016\/j.otc.2021.05.019_bib84","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1177\/0194599811429432","article-title":"Intratympanic treatment of intractable unilateral Meniere disease: gentamicin or dexamethasone? A randomized controlled trial","volume":"146","author":"Casani","year":"2012","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"3","key":"10.1016\/j.otc.2021.05.019_bib85","doi-asserted-by":"crossref","first-page":"171","DOI":"10.7123\/01.EJO.0000418018.88180.0c","article-title":"Intratympanic injection in M\u00e9ni\u00e8re\u2019s disease; symptomatic and audiovestibular; comparative, prospective randomized 1-year control study","volume":"28","author":"ElBeltagy","year":"2012","journal-title":"Egypt J Otolaryngol"},{"issue":"10061","key":"10.1016\/j.otc.2021.05.019_bib86","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1016\/S0140-6736(16)31461-1","article-title":"Intratympanic methylprednisolone versus gentamicin in patients with unilateral M\u00e9ni\u00e8re\u2019s disease: a randomised, double-blind, comparative effectiveness trial","volume":"388","author":"Patel","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.otc.2021.05.019_bib87","doi-asserted-by":"crossref","first-page":"705","DOI":"10.13005\/bpj\/772","article-title":"Comparison the efficacy of intratympanic injections of methylprednisolone and gentamicin to control vertigo in unilateral M\u00e9ni\u00e8re\u2019s disease","volume":"8","author":"Sarafraz","year":"2015","journal-title":"Biomed Pharmacol J"},{"key":"10.1016\/j.otc.2021.05.019_bib88","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1186\/1745-6215-15-328","article-title":"Intratympanic gentamicin treatment for M\u00e9ni\u00e8re\u2019s disease: a randomized, double-blind, placebo-controlled trial on dose efficacy\u2014results of a prematurely ended study","volume":"15","author":"Bremer","year":"2014","journal-title":"Trials"},{"issue":"4","key":"10.1016\/j.otc.2021.05.019_bib89","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/00129492-200407000-00023","article-title":"Intratympanic gentamicin therapy for M\u00e9ni\u00e8re\u2019s disease: a meta-analysis","volume":"25","author":"Chia","year":"2004","journal-title":"Otol Neurotol"},{"issue":"1","key":"10.1016\/j.otc.2021.05.019_bib90","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1055\/s-0039-3400315","article-title":"Cerebellar dizziness and vertigo: etiologies, diagnostic assessment, and treatment","volume":"40","author":"Zwergal","year":"2020","journal-title":"Semin Neurol"},{"issue":"03","key":"10.1016\/j.otc.2021.05.019_bib91","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11940-019-0549-2","article-title":"The comprehensive management of cerebellar ataxia in adults","volume":"21","author":"Stephen","year":"2019","journal-title":"Curr Treat Options Neurol"},{"issue":"01","key":"10.1016\/j.otc.2021.05.019_bib92","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1212\/CPJ.0000000000000321","article-title":"Aminopyridines for the treatment of neurologic disorders","volume":"7","author":"Strupp","year":"2017","journal-title":"Neurol Clin Pract"},{"issue":"01","key":"10.1016\/j.otc.2021.05.019_bib93","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2174\/1570159X16666180905093535","article-title":"Aminopyridines and acetyl-DL-leucine: new therapies in cerebellar disorders","volume":"17","author":"Kalla","year":"2019","journal-title":"Curr Neuropharmacol"},{"issue":"11","key":"10.1016\/j.otc.2021.05.019_bib94","first-page":"2491","article-title":"4-aminopyridine and cerebellar gait: a retrospective case series","volume":"259","author":"Schniepp","year":"2012","journal-title":"J\u00a0Neurol"},{"issue":"02","key":"10.1016\/j.otc.2021.05.019_bib95","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1212\/01.WNL.0000078893.41040.56","article-title":"Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study","volume":"61","author":"Strupp","year":"2003","journal-title":"Neurology"},{"issue":"04","key":"10.1016\/j.otc.2021.05.019_bib96","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/WNO.0b013e3182258086","article-title":"Comparison of 10-mg doses of 4-aminopyridine and 3,4-diaminopyridine for the treatment of downbeat nystagmus","volume":"31","author":"Kalla","year":"2011","journal-title":"J\u00a0Neuroophthalmol"},{"issue":"12","key":"10.1016\/j.otc.2021.05.019_bib97","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1136\/jnnp-2012-304736","article-title":"A\u00a0randomised double-blind, cross-over trial of 4-aminopyridine for downbeat nystagmus\u2013 effects on slow phase eye velocity, postural stability, locomotion and symptoms","volume":"84","author":"Claassen","year":"2013","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"08","key":"10.1016\/j.otc.2021.05.019_bib98","first-page":"1992","article-title":"Dalfampridine in patients with downbeat nystagmus\u2013an observational study","volume":"260","author":"Claassen","year":"2013","journal-title":"J\u00a0Neurol"},{"issue":"13","key":"10.1016\/j.otc.2021.05.019_bib99","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1212\/WNL.0b013e3182a55f6d","article-title":"Effect of chlorzoxazone in patients with downbeat nystagmus: a pilot trial","volume":"81","author":"Feil","year":"2013","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.otc.2021.05.019_bib100","first-page":"2556","article-title":"Effects of acetyl-DL-leucine in patients with cerebellar ataxia: a case series","volume":"260","author":"Strupp","year":"2013","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.otc.2021.05.019_bib101","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40673-016-0046-2","article-title":"Acetyl-DL-leucine improves gait variability in patients with cerebellar ataxia-a case series","volume":"3","author":"Schniepp","year":"2016","journal-title":"Cerebellum Ataxias"},{"key":"10.1016\/j.otc.2021.05.019_bib102","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1136\/jnnp.54.7.627","article-title":"The effects of baclofen and cholinergic drugs on upbeat and downbeat nystagmus","volume":"54","author":"Dieterich","year":"1991","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.otc.2021.05.019_bib103","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/ana.410080611","article-title":"Treatment of periodic alternating nystagmus","volume":"8","author":"Halmagyi","year":"1980","journal-title":"Ann Neurol"},{"key":"10.1016\/j.otc.2021.05.019_bib104","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ana.410350312","article-title":"Muscarinic antagonists in the treatment of acquired pendular and downbeat nystagmus: a double-blind, randomized trial of three intravenous drugs","volume":"35","author":"Barton","year":"1994","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.otc.2021.05.019_bib105","first-page":"322","article-title":"Acquired pendular nystagmus in multiple sclerosis: an examiner-blind cross-over treatment study of memantine and gabapentin","volume":"257","author":"Starck","year":"2010","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.otc.2021.05.019_bib106","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1186\/s10194-015-0516-6","article-title":"Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial","volume":"16","author":"Gaul","year":"2015","journal-title":"J\u00a0Headache Pain"},{"issue":"2","key":"10.1016\/j.otc.2021.05.019_bib107","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/WNO.0000000000000791","article-title":"Vestibular migraine: how to sort it out and what to do about it","volume":"39","author":"Beh","year":"2019","journal-title":"J\u00a0Neuroophthalmol"},{"key":"10.1016\/j.otc.2021.05.019_bib108","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1212\/01.WNL.0000049476.40047.A3","article-title":"Zolmitriptan for treatment of migrainous vertigo: a placebo-controlled trial","volume":"60","author":"Neuhauser","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.otc.2021.05.019_bib109","first-page":"350","article-title":"Efficacy of antimigrainous therapy in the treatment of migraine associated dizziness","volume":"18","author":"Bikhazi","year":"1997","journal-title":"Am J Otol"},{"key":"10.1016\/j.otc.2021.05.019_bib110","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/j.1526-4610.2009.01474.x","article-title":"Migrainous vertigo responsive to intravenous methylprednisolone: case reports","volume":"49","author":"Prakash","year":"2009","journal-title":"Headache"},{"issue":"4 Headache","key":"10.1016\/j.otc.2021.05.019_bib111","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1212\/CON.0000000000000199","article-title":"Preventive migraine treatment","volume":"21","author":"Silberstein","year":"2015","journal-title":"Continuum (Minneap Minn)"},{"issue":"3","key":"10.1016\/j.otc.2021.05.019_bib112","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/1756285611401647","article-title":"Management of vestibular migraine","volume":"4","author":"Bisdorff","year":"2011","journal-title":"Ther Adv Neurol Disord"},{"issue":"6","key":"10.1016\/j.otc.2021.05.019_bib113","article-title":"Pharmacological agents for the prevention of vestibular migraine","volume":"2015","author":"Maldonado Fern\u00e1ndez","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.otc.2021.05.019_bib114","doi-asserted-by":"crossref","first-page":"e0130733","DOI":"10.1371\/journal.pone.0130733","article-title":"A\u00a0comparative effectiveness meta-analysis of drugs for the prophylaxis of migraine headache","volume":"10","author":"Jackson","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.otc.2021.05.019_bib115","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1007\/s00405-013-2786-4","article-title":"Flunarizine in the prophylaxis of migrainous vertigo: a randomized controlled trial","volume":"271","author":"Lepcha","year":"2014","journal-title":"Euro Arch Oto Rhino Laryngol"},{"issue":"1","key":"10.1016\/j.otc.2021.05.019_bib116","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/lary.25445","article-title":"Propranolol and venlafaxine for vestibular migraine prophylaxis: a randomized controlled trial","volume":"126","author":"Salviz","year":"2016","journal-title":"Laryngoscope"},{"key":"10.1016\/j.otc.2021.05.019_bib117","first-page":"231","article-title":"Cinnarizine for the prophylaxis of migraine associated vertigo: a retrospective study","volume":"3","author":"Taghdiri","year":"2014","journal-title":"Spring"},{"issue":"10","key":"10.1016\/j.otc.2021.05.019_bib118","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1007\/s10072-015-2270-6","article-title":"Fixed combination of cinnarizine and dimenhydrinate in the prophylactic therapy of vestibular migraine: an observational study","volume":"36","author":"Teggi","year":"2015","journal-title":"Neurol Sci"},{"issue":"7","key":"10.1016\/j.otc.2021.05.019_bib119","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1017\/S002221512000095X","article-title":"Pharmacotherapy failure and progression to botulinum toxin injection in vestibular migraine","volume":"134","author":"Liu","year":"2020","journal-title":"J\u00a0Laryngol Otol"},{"key":"10.1016\/j.otc.2021.05.019_bib120","doi-asserted-by":"crossref","first-page":"e027953","DOI":"10.1136\/bmjopen-2018-027953","article-title":"Cochrane systematic review and meta-analysis of botulinum toxin for the prevention of migraine","volume":"9","author":"Herd","year":"2019","journal-title":"BMJ Open"},{"issue":"7","key":"10.1016\/j.otc.2021.05.019_bib121","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1177\/0333102410364676","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial","volume":"30","author":"Aurora","year":"2010","journal-title":"Cephalalgia"},{"issue":"7","key":"10.1016\/j.otc.2021.05.019_bib122","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1177\/0333102410364677","article-title":"OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial","volume":"30","author":"Diener","year":"2010","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.otc.2021.05.019_bib123","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s10194-019-1038-4","article-title":"Current and emerging evidence-based treatment options in chronic migraine: a narrative review","volume":"20","author":"Agostoni","year":"2019","journal-title":"J\u00a0Headache Pain"},{"issue":"12","key":"10.1016\/j.otc.2021.05.019_bib125","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11940-018-0535-0","article-title":"Treatment of Persistent Postural-Perceptual Dizziness (PPPD) and Related Disorders","volume":"20","author":"Popkirov","year":"2018","journal-title":"Curr Treat Options Neurol"},{"issue":"5","key":"10.1016\/j.otc.2021.05.019_bib126","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1212\/01.CON.0000421622.56525.58","article-title":"Chronic subjective dizziness","volume":"18","author":"Staab","year":"2012","journal-title":"Continuum (Minneap Minn)"},{"issue":"5","key":"10.1016\/j.otc.2021.05.019_bib127","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1001\/archotol.128.5.554","article-title":"Serotonin reuptake inhibitors for dizziness with psychiatric symptoms","volume":"128","author":"Staab","year":"2002","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"9","key":"10.1016\/j.otc.2021.05.019_bib128","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1097\/00005537-200409000-00025","article-title":"A\u00a0prospective trial of sertraline for chronic subjective dizziness","volume":"114","author":"Staab","year":"2004","journal-title":"Laryngoscope"},{"issue":"8","key":"10.1016\/j.otc.2021.05.019_bib129","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1001\/archotol.131.8.675","article-title":"Chronic dizziness and anxiety: effect of course of illness on treatment outcome","volume":"131","author":"Staab","year":"2005","journal-title":"Arch Otolaryngolheadneck Surg"},{"issue":"1","key":"10.1016\/j.otc.2021.05.019_bib130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/VES-2007-17101","article-title":"Effects of fluvoxamine on anxiety, depression, and subjective handicaps of chronic dizziness patients with or without neuro-otologic diseases","volume":"17","author":"Horii","year":"2007","journal-title":"J\u00a0Vestib Res"},{"issue":"6","key":"10.1016\/j.otc.2021.05.019_bib131","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3233\/VES-2011-0426","article-title":"Clinical clues to a dizzying headache","volume":"21","author":"Staab","year":"2011","journal-title":"J\u00a0Vestib Res"},{"key":"10.1016\/j.otc.2021.05.019_bib132","first-page":"65","article-title":"Vestibular migraine and persistent postural perceptual dizziness: results of a double-blind, parallel group, pharmacological dissection trial using verapamil and sertraline","volume":"35","author":"Staab","year":"2015","journal-title":"Cephalgia"},{"key":"10.1016\/j.otc.2021.05.019_bib133","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archotol.125.6.615","article-title":"Mal de debarquement","volume":"125","author":"Hain","year":"1999","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.otc.2021.05.019_bib134","first-page":"843","article-title":"Mal de debarquement syndrome: a systematic review","volume":"263","author":"Van Ombergen","year":"2016","journal-title":"J\u00a0Neurol"},{"issue":"5","key":"10.1016\/j.otc.2021.05.019_bib135","first-page":"E1653","article-title":"The Interconnections of mal de D\u00e9barquement syndrome and vestibular migraine","volume":"131","author":"Beh","year":"2020","journal-title":"Laryngoscope"},{"issue":"7","key":"10.1016\/j.otc.2021.05.019_bib136","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/lary.26299","article-title":"Management of mal de debarquement syndrome as vestibular migraines","volume":"127","author":"Ghavami","year":"2017","journal-title":"Laryngoscope"},{"key":"10.1016\/j.otc.2021.05.019_bib137","doi-asserted-by":"crossref","first-page":"943","DOI":"10.3389\/fneur.2018.00943","article-title":"Examination of current treatments and symptom management strategies used by patients with mal de debarquement syndrome","volume":"9","author":"Canceri","year":"2018","journal-title":"Front Neurol"}],"container-title":["Otolaryngologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0030666521001201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0030666521001201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T14:53:22Z","timestamp":1758466402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0030666521001201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":136,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0030666521001201"],"URL":"https:\/\/doi.org\/10.1016\/j.otc.2021.05.019","relation":{},"ISSN":["0030-6665"],"issn-type":[{"value":"0030-6665","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current and Emerging Medical Therapies for Dizziness","name":"articletitle","label":"Article Title"},{"value":"Otolaryngologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.otc.2021.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}